Clinical, immunological, and virological features of 10 LKM1 positive patients
| Patient | Sex | Age (y) | Diagnosis | IAHG score | Recombinant CYP2D6 | Native CYP2D6 | LKM1 titre | HCV RNA |
| 1 | F | 26 | Type 2 AIH | 19 (d) | Positive | Positive | <1:4000 | Negative |
| 2 | F | 8 | Type 2 AIH | 20 (d) | Positive | Positive | <1:4000 | Negative |
| 3 | F | 26 | Type 2 AIH | 18 (d) | Positive | Positive | 1:2000 | Negative |
| 4 | F | 18 | Type 2 AIH | 18 (d) | Positive | Positive | 1:1000 | Negative |
| 5 | M | 23 | Type 2 AIH | 17 (d) | Positive | Positive | 1:500 | Negative |
| 6 | M | 18 | HCV related | 7 | Positive | Positive | <1:4000 | Positive |
| 7 | F | 32 | HCV related | 7 | Positive | Positive | <1:4000 | Positive |
| 8 | F | 60 | HCV related | 5 | Positive | Positive | 1:2000 | Positive |
| 9 | F | 29 | HCV related | 5 | Positive | Positive | 1:1000 | Positive |
| 10 | F | 32 | HCV related | 6 | Positive | Positive | 1:500 | Positive |
AIH, autoimmune hepatitis; IAHG, International Autoimmune Hepatitis Group; d, “definite” diagnosis of AIH; LKM1, liver/kidney microsomal antibody type 1.